• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neoadjuvant treatment of rectal cancer: where are we now?

作者信息

Kalyan Aparna, Rozelle Shaina, Benson Al

机构信息

Developmental Therapeutics Program of Division of Hematology & Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL USA Division of Hematology & Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL USA

Division of Hematology & Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL USA.

出版信息

Gastroenterol Rep (Oxf). 2016 Aug;4(3):206-9. doi: 10.1093/gastro/gow017. Epub 2016 Jul 12.

DOI:10.1093/gastro/gow017
PMID:27412436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4976683/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4230/4976683/6d50505c9f87/gow017f2p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4230/4976683/11e143312444/gow017f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4230/4976683/6d50505c9f87/gow017f2p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4230/4976683/11e143312444/gow017f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4230/4976683/6d50505c9f87/gow017f2p.jpg

相似文献

1
Neoadjuvant treatment of rectal cancer: where are we now?直肠癌的新辅助治疗：我们目前处于什么阶段？
Gastroenterol Rep (Oxf). 2016 Aug;4(3):206-9. doi: 10.1093/gastro/gow017. Epub 2016 Jul 12.
2
Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.新辅助放化疗后残留直肠癌（ypT0-2）经肛门内镜微创手术：另需谨慎。
Dis Colon Rectum. 2013 Jan;56(1):6-13. doi: 10.1097/DCR.0b013e318273f56f.
3
Accuracy of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy.新辅助放化疗后内镜超声对直肠癌再分期的准确性
Am J Gastroenterol. 2004 Jan;99(1):109-12. doi: 10.1046/j.1572-0241.2003.04019.x.
4
Oncologic outcomes of neoadjuvant chemoradiation for locally advanced rectal cancer: a single-institution experience.局部进展期直肠癌新辅助放化疗的肿瘤学结局：单机构经验。
Ann Acad Med Singap. 2014 Dec;43(12):569-75.
5
Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.表皮生长因子受体、血管内皮生长因子和缺氧诱导因子-1 的基因表达谱，特别是与直肠癌手术后新辅助放化疗的局部反应性和疾病复发的关系。
Clin Oncol (R Coll Radiol). 2010 May;22(4):272-80. doi: 10.1016/j.clon.2010.01.001. Epub 2010 Feb 1.
6
The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.组织诊断在局部晚期直肠癌新辅助放化疗前的作用。
Colorectal Dis. 2014 Oct;16(10):783-7. doi: 10.1111/codi.12653.
7
Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?新辅助放化疗后哪些患者应行侧方盆腔淋巴结清扫术？
Dis Colon Rectum. 2019 Oct;62(10):1158-1166. doi: 10.1097/DCR.0000000000001465.
8
Genetic polymorphisms in 5-Fluorouracil-related enzymes predict pathologic response after neoadjuvant chemoradiation for rectal cancer.5-氟尿嘧啶相关酶的基因多态性可预测直肠癌新辅助放化疗后的病理反应。
Surgery. 2016 Nov;160(5):1326-1332. doi: 10.1016/j.surg.2016.05.017. Epub 2016 Jul 14.
9
Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.黏液组织学对直肠癌中基于卡培他滨的新辅助放化疗后病理完全缓解率的预测意义：一项对比研究
J Gastrointest Cancer. 2019 Dec;50(4):716-722. doi: 10.1007/s12029-018-0136-x.
10
Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.他汀类药物治疗与直肠癌新辅助放化疗的病理反应改善相关。
Dis Colon Rectum. 2013 Nov;56(11):1217-27. doi: 10.1097/DCR.0b013e3182a4b236.

引用本文的文献

1
Alteration of Apparent Diffusion Coefficient Measurements Predict Survival Outcomes During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.表观扩散系数测量值的改变可预测局部晚期直肠癌新辅助放化疗期间的生存结果。
In Vivo. 2025 Mar-Apr;39(2):927-935. doi: 10.21873/invivo.13897.
2
Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy.新辅助放化疗后局部进展期直肠癌患者复发预测的肿瘤免疫微环境生物标志物
Cancers (Basel). 2024 Sep 30;16(19):3353. doi: 10.3390/cancers16193353.
3
Novel regimens and treatment strategies in neoadjuvant therapy for colorectal cancer: A systematic review.

本文引用的文献

1
Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.放化疗后观察等待与手术切除治疗直肠癌患者的对比（OnCoRe 项目）：倾向评分匹配队列分析。
Lancet Oncol. 2016 Feb;17(2):174-183. doi: 10.1016/S1470-2045(15)00467-2. Epub 2015 Dec 17.
2
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.使用新辅助放化疗和局部切除对临床T2N0期低位直肠癌进行器官保留（ACOSOG Z6041）：一项开放标签、单臂、多机构的2期试验结果
Lancet Oncol. 2015 Nov;16(15):1537-1546. doi: 10.1016/S1470-2045(15)00215-6. Epub 2015 Oct 22.
3
结直肠癌新辅助治疗中的新型方案和治疗策略：一项系统评价。
Int J Health Sci (Qassim). 2024 Sep-Oct;18(5):43-58.
4
Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.全身炎症反应指数（SIRI）对局部进展期直肠癌新辅助放化疗疗效及预后的预测作用。
BMC Surg. 2024 Mar 13;24(1):89. doi: 10.1186/s12893-024-02384-5.
5
Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer.循环 miRNA 特征可预测局部晚期直肠癌术前放化疗的反应。
JCO Precis Oncol. 2021 Dec 2;5. doi: 10.1200/PO.21.00015. eCollection 2021.
6
CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA.癌胚抗原下降可预测基线癌胚抗原升高的局部晚期直肠癌患者的肿瘤消退及预后。
J Cancer. 2020 Sep 23;11(22):6565-6570. doi: 10.7150/jca.49252. eCollection 2020.
7
Nomogram for predicting pathological complete response and tumor downstaging in patients with locally advanced rectal cancer on the basis of a randomized clinical trial.基于一项随机临床试验的局部晚期直肠癌患者病理完全缓解和肿瘤降期预测列线图
Gastroenterol Rep (Oxf). 2020 Feb 8;8(3):234-241. doi: 10.1093/gastro/goz073. eCollection 2020 Jun.
8
Preoperative assessment of lymph node metastasis in clinically node-negative rectal cancer patients based on a nomogram consisting of five clinical factors.基于包含五个临床因素的列线图对临床淋巴结阴性直肠癌患者进行术前淋巴结转移评估。
Ann Transl Med. 2019 Oct;7(20):543. doi: 10.21037/atm.2019.09.127.
9
Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer.定量荧光内镜检查：一种评估局部晚期直肠癌新辅助治疗反应的创新内镜检查方法。
Gut. 2020 Mar;69(3):406-410. doi: 10.1136/gutjnl-2019-319755. Epub 2019 Sep 18.
10
Association of tumor differentiation and prognosis in patients with rectal cancer undergoing neoadjuvant chemoradiation therapy.接受新辅助放化疗的直肠癌患者肿瘤分化与预后的相关性
Gastroenterol Rep (Oxf). 2019 Aug;7(4):283-290. doi: 10.1093/gastro/goy045. Epub 2018 Dec 22.
Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer.新辅助放化疗与直肠癌的病理完全缓解。
Gastroenterol Rep (Oxf). 2015 Nov;3(4):277-88. doi: 10.1093/gastro/gov039. Epub 2015 Aug 19.
4
Neoadjuvant therapy before surgical treatment.手术治疗前的新辅助治疗。
EJC Suppl. 2013 Sep;11(2):45-59. doi: 10.1016/j.ejcsup.2013.07.032.
5
Cancer statistics, 2015.癌症统计数据，2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
6
Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter Trial.通过高分辨率磁共振成像筛选的中危直肠腺癌患者的术前化疗：GEMCAD 0801 II期多中心试验
Oncologist. 2014 Oct;19(10):1042-3. doi: 10.1634/theoncologist.2014-0233. Epub 2014 Sep 10.
7
Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial.局部进展期直肠癌患者新辅助化疗不常规应用放疗：一项初步试验。
J Clin Oncol. 2014 Feb 20;32(6):513-8. doi: 10.1200/JCO.2013.51.7904. Epub 2014 Jan 13.
8
Evolving role of neoadjuvant therapy in rectal cancer.新辅助治疗在直肠癌中的作用演变。
Curr Treat Options Oncol. 2013 Sep;14(3):350-64. doi: 10.1007/s11864-013-0242-8.
9
Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.接受新辅助治疗的 II/III 期直肠癌患者的术后辅助化疗应用：美国国家综合癌症网络分析。
J Clin Oncol. 2013 Jan 1;31(1):30-8. doi: 10.1200/JCO.2011.40.3188. Epub 2012 Nov 19.
10
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.局部进展期直肠癌术前与术后放化疗的比较：中位随访 11 年后德国 CAO/ARO/AIO-94 随机 III 期临床试验结果。
J Clin Oncol. 2012 Jun 1;30(16):1926-33. doi: 10.1200/JCO.2011.40.1836. Epub 2012 Apr 23.